These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Interchangeability of Haemophilus influenzae type b vaccines in the primary series: evaluation of a two-dose mixed regimen. Bewley KM, Schwab JG, Ballanco GA, Daum RS. Pediatrics; 1996 Nov 01; 98(5):898-904. PubMed ID: 8909483 [Abstract] [Full Text] [Related]
10. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age. Berkowitz CD, Ward JI, Chiu CE, Marcy SM, Gordon L, Hendley JO, Meier K, Marchant CD, McVerry P. Pediatrics; 1990 Mar 01; 85(3):288-93. PubMed ID: 2304781 [Abstract] [Full Text] [Related]
11. Haemophilus influenzae meningitis in Manitoba and the Keewatin District, NWT: potential for mass vaccination. Hammond GW, Rutherford BE, Malazdrewicz R, MacFarlane N, Pillay N, Tate RB, Nicolle LE, Postl BD, Stiver HG. CMAJ; 1988 Oct 15; 139(8):743-7. PubMed ID: 3262404 [Abstract] [Full Text] [Related]
12. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants. Granoff DM, Holmes SJ, Belshe RB, Osterholm MT, McHugh JE, Anderson EL. JAMA; 1994 Oct 12; 272(14):1116-21. PubMed ID: 7933324 [Abstract] [Full Text] [Related]
13. Immunogenicity of Haemophilus influenzae type b conjugate vaccines in infant rhesus monkeys. Vella PP, Ellis RW. Pediatr Res; 1991 Jan 12; 29(1):10-3. PubMed ID: 2000253 [Abstract] [Full Text] [Related]
14. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses. Yogev R, Arditi M, Chadwick EG, Amer MD, Sroka PA. Pediatrics; 1990 Apr 12; 85(4 Pt 2):690-3. PubMed ID: 2107520 [Abstract] [Full Text] [Related]
17. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation. Sood SK, Daum RS. Pediatrics; 1990 Apr 12; 85(4 Pt 2):698-704. PubMed ID: 2107522 [Abstract] [Full Text] [Related]
18. Studies on the combined administration of Haemophilus influenzae type B--diphtheria toxoid conjugate vaccine (PRP-D) and DTP. Gordon LK. Dev Biol Stand; 1986 Apr 12; 65():113-21. PubMed ID: 3549393 [Abstract] [Full Text] [Related]
19. Safety evaluation of PRP-D Haemophilus influenzae type b conjugate vaccine in children immunized at 18 months of age and older: follow-up study of 30,000 children. Vadheim CM, Greenberg DP, Marcy SM, Froeschle J, Ward JI. Pediatr Infect Dis J; 1990 Aug 12; 9(8):555-61. PubMed ID: 2235171 [Abstract] [Full Text] [Related]
20. Haemophilus influenzae type b immunization of children with sickle cell diseases. Frank AL, Labotka RJ, Rao S, Frisone LR, McVerry PH, Samuelson JS, Maurer H, Yogev R. Pediatrics; 1988 Oct 12; 82(4):571-5. PubMed ID: 3262857 [Abstract] [Full Text] [Related] Page: [Next] [New Search]